InfuSystem Holdings (INFU) Total Current Liabilities (2010 - 2026)
InfuSystem Holdings (INFU) reported Total Current Liabilities of $17.1 million for Q1 2026, up 7.35% on a YoY basis from $16.0 million in Q1 2025, and down 15.06% quarter-over-quarter from $20.2 million in Q4 2025.
InfuSystem Holdings (INFU) Total Current Liabilities (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Total Current Liabilities for 17 years, with the latest figure at $17.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 7.35% year-over-year to $17.1 million; the trailing twelve-month figure through Mar 2026 stood at $17.1 million (up 7.35% YoY), and the FY2025 full-year result was $20.2 million, up 14.27% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $17.1 million, down from $20.2 million in the prior quarter.
- The five-year high for Total Current Liabilities was $20.2 million in Q4 2025, with the low at $12.7 million in Q3 2022.
- Historically, Total Current Liabilities has averaged $15.8 million across 5 years, with a median of $15.9 million in 2025.
- Annual changes were most pronounced in 2022 — Total Current Liabilities retreated 12.09% — and 2024, when it gained 24.28%.
- InfuSystem Holdings' Total Current Liabilities stood at $14.5 million in 2022, then increased by 8.61% to $15.7 million in 2023, then grew by 12.4% to $17.7 million in 2024, then grew by 14.27% to $20.2 million in 2025, then retreated by 15.06% to $17.1 million in 2026.
- The last three Total Current Liabilities figures came in at $17.1 million (Q1 2026), $20.2 million (Q4 2025), and $18.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | 17.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.14 Mn |
| Dec 31, 2025 | 20.18 Mn |
| Sep 30, 2025 | 18.72 Mn |
| Jun 30, 2025 | 15.86 Mn |
| Mar 31, 2025 | 15.97 Mn |
| Dec 31, 2024 | 17.66 Mn |
| Sep 30, 2024 | 16.94 Mn |
| Jun 30, 2024 | 15.88 Mn |
| Mar 31, 2024 | 17.31 Mn |
| Dec 31, 2023 | 15.71 Mn |
| Sep 30, 2023 | 14.28 Mn |
| Jun 30, 2023 | 12.87 Mn |
| Mar 31, 2023 | 13.93 Mn |
| Dec 31, 2022 | 14.47 Mn |
| Sep 30, 2022 | 12.73 Mn |
| Jun 30, 2022 | 14.43 Mn |
| Mar 31, 2022 | 13.94 Mn |
| Dec 31, 2021 | 12.90 Mn |
| Sep 30, 2021 | 14.49 Mn |
| Jun 30, 2021 | 15.85 Mn |